Copper peptide serum: what it does, label checks and what studies found

A copper peptide serum is a cosmetic containing GHK-Cu, a three-amino-acid peptide bound to copper. Lab studies are promising, but the human evidence is thin, and no one has shown a best strength. Serums are cosmetics, FDA does not approve them or review whether they work, and PeptideSorted names no products. What follows is about using the label and the evidence to judge a bottle. The skincare peptides index has the related guides, and the GHK-Cu topical evidence page sets out each study in full.

What does a copper peptide serum do?

It is sold to firm skin and soften fine lines, and the proof in people is much weaker than the proof in cells. A 2026 systematic review in Aesthetic Surgery Journal found 20 eligible studies. Eighteen were preclinical and only 2 were randomized controlled trials. Here is how the common claims hold up.

Who wrote the literature matters here. A 2026 systematic review found that about 35% of the primary GHK-Cu papers in its window included the researcher who first isolated the peptide or a colleague, both tied to a company selling copper peptide products. Its authors said this limits how independent the evidence is. A separate 2024 review noted a “surprising absence of clinical studies” for GHK-Cu and its palmitoyl form.

Is a copper peptide serum better than retinol?

Nothing shows that it is. No published study compares a modern copper peptide serum with retinol. The early biopsy study above is the only comparison with retinoic acid we found, and it was small and never fully published. Prescription tretinoin has an FDA label, while a copper peptide serum has neither that nor comparable trials. Daily sunscreen has the strongest prevention evidence for aging skin: 24% less skin aging in a randomized trial of 903 adults over 4.5 years. The peptides for skin guide compares these options side by side.

Finding it on the label

The sample below shows both ingredients on one list, which is how many shoppers mix them up.

Position on the list. US rules require ingredients in descending order of amount, except that anything at 1% or less may be listed in any order after the ingredients above 1%. Because published studies used roughly 0.05% to 2%, where copper tripeptide-1 sits near the end of a list tells you little about how much is there.

What concentration did the studies use?

Studies ranged from about 0.05% to 2%, and none fixed a best strength.

Because the strongest cosmetic studies never reported a concentration, there is no evidence-based minimum to look for. A serum that states its percentage at least lets you compare it with this range. The GHK-Cu dosage page converts percentages to milligrams.

Stability and formulation

Laboratory findings from a 2024 review of GHK-Cu formulation:

• It dissolves easily in water (about 325 mg/mL) and is strongly water-loving, which is why serums are a common format.
• Skin-like pH is fine. Solutions at pH 5.5 and 7.4 showed no detectable breakdown at 60 °C over 14 days.
• Oxidizing conditions are the main threat. In a 0.5% hydrogen peroxide solution, only 84.2% of GHK-Cu remained after one hour, the worst result of the stress tests.
• Some formula ingredients matter. In one test, a charged surfactant (dicetyl phosphate) made GHK-Cu less stable inside lipid carriers, while carriers without it showed no breakdown after a month at 40 °C.

These were laboratory tests of raw material and carriers. They do not tell you how long any given product stays potent once opened.

Does GHK-Cu get into skin?

Not easily through intact skin. In a 2015 laboratory study, almost no peptide passed through untreated human skin in nine hours, while skin pre-treated with microneedles let 134 nanomoles through. Reviews describe liposomes and other carriers that improve passage in the lab. So the formula and the way it is applied may matter as much as the percentage. It is also why a result in cultured cells, where the peptide sits directly on the cells, says little about a bottle used on intact skin at home.

Mixing with other actives: what is actually known

Advice on what not to combine with copper peptides is widely repeated, and very little of it has data behind it.

The general advice that does have a source comes from the American Academy of Dermatology (AAD): start with one anti-aging product, because using several at the same time can irritate skin.

Side effects and patch testing

The safety record is mostly silence. A 2024 review found no published studies of GHK-Cu’s side effects, and a 2026 review noted the hyperpigmentation flag in one microneedling study. Neither means the ingredient is risk-free. It means the question has barely been studied.

The AAD recommends testing a new product on a quarter-sized spot, such as the underside of the arm, twice a day for 7 to 10 days, and not using it if the skin turns red, itchy or swollen. It also advises stopping any anti-aging product that stings, burns or tingles. Anything severe that does not settle is one for a dermatologist.

What to expect

Expect modest changes at best. The AAD says most anti-aging products take at least six weeks to work, and sometimes up to three months, and that a moisturizer can plump fine lines within days, so a fast change is not proof the copper peptide did it. It also says effective products come in all price ranges, so a high price is no evidence of potency. If a product claims to “regenerate cells” or restore hair growth, FDA treats that as a drug claim, and the product is being sold as an unapproved drug.

Serum is not injection

Copper peptide serums are legal cosmetics. Injectable GHK-Cu is an unapproved drug. FDA held it in its significant-safety-risk category for compounding from September 2023 until the nomination was withdrawn in April 2026, and it still says compounded injectable GHK-Cu may pose immune-reaction risk from aggregation and peptide impurities, with limited human data. A September 2026 NPR report found no published human data showing injection is safe or effective.

As of November 2, 2026, HHS says it does not intend to take enforcement action against pharmacies compounding six named peptides under strict conditions. None of the six is FDA-approved, the policy approves nothing, and GHK-Cu is not on the list, so injectable GHK-Cu still has no compounding route. Vials labeled “research use only” are not legal to use on people. The GHK-Cu overview covers that side.